Evoke Pharma
EVOK
EVOK
25 hedge funds and large institutions have $8.74M invested in Evoke Pharma in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+6
Holders Change %
+31.58%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
4
Closed
3
Calls
$1.36M
Puts
$825K
Net Calls
+$532K
Net Calls Change
+$532K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
| 2 |
Morgan Stanley
New York
|
+$312K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$287K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$108K |
| 5 |
Renaissance Technologies
New York
|
+$105K |
Top Sellers
| 1 |
BlackRock
New York
|
-$333K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$161K |
| 3 |
Goldman Sachs
New York
|
-$125K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$7.49K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
Goldman Sachs
New York
| – | -$125K | -244 | Closed |
|
|
27
Acadian Asset Management
Boston,
Massachusetts
| – | -$22K | -43 | Closed |
|
|
OIA
28
Optimum Investment Advisors
Chicago,
Illinois
| – | -$3K | -6 | Closed |
|